Search

Author/Creator Lavy, A

1. Corrigendum: Methotrexate in Chronic Active Crohn's Disease: A Double‐Blind, Randomized, Israeli Multicenter Trial. (April 2015)

Authors:
Oren, R; Moshkowitz, M; Odes, S; Becker, S; Keter, D; Pomeranz, I; Shirin, C; Reisfeld, I; Broide, E; Lavy, A; Fich, A; Eliakim, R; Patz, J; Villa, Y; Arber, N; Gilat, T
Journal:
American journal of gastroenterology
Issue:
Volume 110:Number 4(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial. (14th July 2015)

Authors:
Israeli, E; Goldin, E; Fishman, S; Konikoff, F; Lavy, A; Chowers, Y; Melzer, E; Lahat, A; Mahamid, M; Shirin, H; Nussinson, E; Segol, O; Ben Ya'acov, A; Shabbat, Y; Ilan, Y
Journal:
Clinical and experimental immunology
Issue:
Volume 181:Number 2(2015:Aug.)
Page Start:
362
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗